AI Terminal
HIKMA Pharmaceuticals PLC
Share Issue/Capital Change • Oct 4, 2021
4841_rns_2021-10-04_5be8d635-2721-41f3-a486-90b0537a4c69.html
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 9028N
Hikma Pharmaceuticals Plc
04 October 2021
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 4 October 2021
| Name of applicant: | Hikma Pharmaceuticals PLC | ||
| Name of scheme: | Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP") | ||
| Period of return | From: 1 April 2021 | To: | 30 September 2021 |
| Balance of unallotted securities under scheme(s) from previous return: | SOP: 792,700 Ordinary Shares of 10 pence | ||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | SOP: 0 Ordinary Shares of 10 pence | ||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | SOP: 0 Ordinary Shares of 10 pence | ||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | SOP: 792,700 Ordinary Shares of 10 pence |
| Name of contact: | Peter Speirs |
| Telephone number of contact: | 0207 399 2772 |
Block Listing Six Monthly Return
Date: 4 October 2021
| Name of applicant: | Hikma Pharmaceuticals PLC | ||
| Name of scheme: | Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP") | ||
| Period of return | From: 1 April 2021 | To: | 30 September 2021 |
| Balance of unallotted securities under scheme(s) from previous return: | LTIP: 57,502 Ordinary Shares of 10 pence | ||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | LTIP: 0 Ordinary Shares of 10 pence | ||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | LTIP: 0 Ordinary Shares of 10 pence | ||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | LTIP: 57,502 Ordinary Shares of 10 pence |
| Name of contact: | Peter Speirs |
| Telephone number of contact: | 0207 399 2772 |
Block Listing Six Monthly Return
Date: 4 October 2021
| Name of applicant: | Hikma Pharmaceuticals PLC | ||
| Name of scheme: | Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("2009 MIP") | ||
| Period of return | From: 1 April 2021 | To: | 30 September 2021 |
| Balance of unallotted securities under scheme(s) from previous return: | 2009 MIP: 136,182 Ordinary Shares of 10 pence | ||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 2009 MIP: 0 Ordinary Shares of 10 pence | ||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 2009 MIP: 136,182 Ordinary Shares of 10 pence | ||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 2009 MIP: 0 Ordinary Shares of 10 pence |
| Name of contact: | Peter Speirs |
| Telephone number of contact: | 0207 399 2772 |
Block Listing Six Monthly Return
Date: 4 October 2021
| Name of applicant: | Hikma Pharmaceuticals PLC | ||
| Name of scheme: | Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP") | ||
| Period of return | From: 1 April 2021 | To: | 30 September 2021 |
| Balance of unallotted securities under scheme(s) from previous return: | 2018 MIP: 1,000,000 Ordinary Shares of 10 pence | ||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 2018 MIP: 0 Ordinary Shares of 10 pence | ||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 2018 MIP: 226,506 Ordinary Shares of 10 pence | ||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 2018 MIP: 773,494 Ordinary Shares of 10 pence |
| Name of contact: | Peter Speirs |
| Telephone number of contact: | 0207 399 2772 |
Block Listing Six Monthly Return
Date: 4 October 2021
| Name of applicant: | Hikma Pharmaceuticals PLC | ||
| Name of scheme: | Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") | ||
| Period of return | From: 1 April 2021 | To: | 30 September 2021 |
| Balance of unallotted securities under scheme(s) from previous return: | EIP: 1,239,967 Ordinary Shares of 10 pence | ||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | EIP: 350,000 Ordinary Shares of 10 pence | ||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | EIP: 340,434 Ordinary Shares of 10 pence | ||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | EIP: 1,249,533 Ordinary Shares of 10 pence |
| Name of contact: | Peter Speirs |
| Telephone number of contact: | 0207 399 2772 |
LEI: 549300BNS685UXH4JI75
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLRUPGCAUUPGURC